Brief: eFFECTOR Therapeutics, Inc. Q2 basic EPS USD -0.17
Aug 8 (Reuters) - eFFECTOR Therapeutics, Inc. Q2 operating income USD -7.855 million. * Q2 operating expenses USD 7.855 million * Q2 basic EPS USD -0.17 * Q2 net income USD -8.364 million
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright